悦心健康(002162) - 2019 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was CNY 347,549,996.90, representing a year-on-year increase of 25.49%[7] - Net profit attributable to shareholders of the listed company was CNY 19,699,893.73, up 72.61% year-on-year[7] - Net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 19,150,329.22, an increase of 74.91% compared to the same period last year[7] - Basic earnings per share were CNY 0.0231, reflecting a growth of 73.68% year-on-year[7] - The net profit for the first nine months of 2019 was RMB 34,217,985.46, reflecting a 73.06% increase from RMB 19,772,378.54 in the same period of 2018[20] - The net profit for Q3 2019 was CNY 19,446,690.42, representing a 80.5% increase from CNY 10,803,280.41 in Q3 2018[47] - The total profit for Q3 2019 was ¥11,949,992.52, which is a 118.1% increase from ¥5,461,908.56 in Q3 2018[50] - Net profit for the current period is ¥34,135,200.71, representing a 67.93% increase compared to ¥20,325,516.40 in the previous period[58] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,274,763,597.85, a decrease of 0.06% compared to the end of the previous year[7] - The company's total liabilities decreased to CNY 1,286,228,524.61 from CNY 1,325,740,926.15, a reduction of about 3%[38] - The total assets of the company as of Q3 2019 amounted to CNY 2,505,841,821.56, compared to CNY 2,356,838,764.21 at the end of Q3 2018, reflecting a growth of 6.3%[44] - The total liabilities increased to CNY 1,106,923,921.17, up from CNY 998,667,308.33, marking an increase of 10.9% year-on-year[44] - The company’s short-term liabilities due within one year decreased by 64.57% to RMB 16,666,725.00, primarily due to repayments of financing lease obligations[16] - The company reported a total asset value of CNY 2,276,109,018.65, with total liabilities amounting to CNY 1,173,325,038.68[70] - The company’s total liabilities included short-term borrowings of CNY 492,450,000.00 and long-term borrowings of CNY 282,916,812.50[71] Cash Flow - The net cash flow from operating activities was CNY 29,015,240.57, a decrease of 2.33% compared to the previous year[7] - The net cash flow from investing activities improved by 85.18% year-on-year, amounting to RMB -8,842,941.89, due to net inflows from financial products and asset disposals[24] - The company’s cash flow from financing activities decreased by 410.45% year-on-year to RMB -149,888,271.39, attributed to reduced bank borrowings and increased operational cash flow[24] - Cash flow from operating activities generated a net amount of ¥70,946,959.27, an increase from ¥55,497,380.16 in the previous period[62] - Cash flow from investing activities resulted in a net outflow of ¥8,842,941.89, compared to a net outflow of ¥59,650,198.16 in the previous period[63] - The net cash flow from financing activities was negative at CNY -60,039,971.81, compared to a positive CNY 4,699,312.56 in the same period last year[67] Shareholder Information - Net profit attributable to the parent company for Q3 2019 was RMB 19,699,893.73, a 72.61% increase compared to RMB 11,412,680.79 in Q3 2018[18] - The total number of ordinary shareholders at the end of the reporting period was 56,743[11] - The equity attributable to shareholders of the parent company increased to CNY 974,102,207.62 from CNY 933,236,725.42, reflecting an increase of approximately 4.4%[39] - The company reported a total equity of CNY 1,398,917,900.39, an increase from CNY 1,358,171,455.88 in the same quarter last year, representing a growth of 3.0%[44] Government Support and Other Income - The company received government subsidies totaling CNY 8,185,528.55 during the reporting period[8] - Investment income rose significantly by 428.50% year-on-year to RMB 1,887,896.42, driven by increased returns from investments in Xinshan Insurance Agency Co., Ltd.[18] - The company reported a significant decrease in interest income by 70.80% year-on-year to RMB 706,925.75, as previous structured financial product returns were reclassified[20] Expenses - The company's management expenses increased by 46.69% year-on-year to RMB 23,706,593.01, primarily due to higher rental and operational costs for newly acquired subsidiaries[18] - Operating costs for the same period were CNY 326,344,673.75, up 23.9% from CNY 263,228,277.27 year-on-year[46] - Research and development expenses for Q3 2019 were CNY 2,386,997.43, a decrease of 23.6% from CNY 3,120,536.03 in Q3 2018[46] - The company's financial expenses for Q3 2019 were ¥6,873,923.53, an increase of 29.0% from ¥5,327,429.32 in the same period last year[50]